- Home
- VIRT vs ZLAB Comparison
VIRT vs ZLAB Comparison
Compare VIRT & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRT
- ZLAB
- Stock Information
- Founded
- VIRT 2008
- ZLAB 2013
- Country
- VIRT United States
- ZLAB China
- Employees
- VIRT N/A
- ZLAB N/A
- Industry
- VIRT Investment Bankers/Brokers/Service
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- VIRT Finance
- ZLAB Health Care
- Exchange
- VIRT Nasdaq
- ZLAB Nasdaq
- Market Cap
- VIRT 3.6B
- ZLAB 4.3B
- IPO Year
- VIRT 2015
- ZLAB 2017
- Fundamental
- Price
- VIRT $42.28
- ZLAB $34.96
- Analyst Decision
- VIRT Hold
- ZLAB Buy
- Analyst Count
- VIRT 8
- ZLAB 5
- Target Price
- VIRT $39.75
- ZLAB $54.28
- AVG Volume (30 Days)
- VIRT 848.8K
- ZLAB 860.8K
- Earning Date
- VIRT 07-30-2025
- ZLAB 08-07-2025
- Dividend Yield
- VIRT 2.26%
- ZLAB N/A
- EPS Growth
- VIRT 122.21
- ZLAB N/A
- EPS
- VIRT 4.40
- ZLAB N/A
- Revenue
- VIRT $2,617,631,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- VIRT N/A
- ZLAB $45.16
- Revenue Next Year
- VIRT N/A
- ZLAB $56.81
- P/E Ratio
- VIRT $9.65
- ZLAB N/A
- Revenue Growth
- VIRT 42.88
- ZLAB 32.56
- 52 Week Low
- VIRT $27.50
- ZLAB $16.01
- 52 Week High
- VIRT $45.77
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- VIRT 42.48
- ZLAB 45.24
- Support Level
- VIRT $42.19
- ZLAB $33.17
- Resistance Level
- VIRT $45.37
- ZLAB $39.64
- Average True Range (ATR)
- VIRT 1.26
- ZLAB 1.19
- MACD
- VIRT -0.26
- ZLAB -0.31
- Stochastic Oscillator
- VIRT 27.84
- ZLAB 22.29
About VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.